Study of HRS9531 for weight loss in overweight or obese adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an oral medication, HRS9531, to help overweight or obese adults lose weight. It may be an option if you have been unable to lose enough weight through diet and exercise alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- Your body mass index (BMI) is 28 or higher, or 24 or higher with a weight-related health condition like high blood pressure or high cholesterol.
- You have been following a diet and exercise plan for at least 3 months, with no more than a 5% change in weight during that time.
- You do not have certain serious health conditions like uncontrolled high blood pressure, diabetes, or a history of weight-loss surgery.
- You are not currently using any medications or treatments that have caused significant weight change in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
This trial is testing how different ways of taking an oral medication (HRS9531) affect the drug levels in the body. It is for healthy men to help find the best dosing conditions for future studies.
This trial tests an investigational injection called HRS-4729 for weight loss in people with obesity. It checks if the drug is safe and effective when used along with diet and exercise.
This study tests whether a new injectable medication called HRS9531 is safe and well-tolerated in teenagers aged 12–17 with obesity. Researchers will monitor how your body handles the medication and whether it affects your weight.
This study tests whether a new medicine called HRS-7535 can help lower blood pressure in people who are overweight or have obesity. You would take it alongside your current blood pressure medications (or as a new treatment) to see if it works better at controlling your blood pressure.
This study tests an injectable medication called HRS9531 for people with obesity and obstructive sleep apnea. The goal is to see if it can help reduce breathing pauses during sleep and promote weight loss.
Hear when a new Chronic Management of Body Weight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.